by admin | Jan 30, 2023 | News & Opinions
By: Stacey DeLoye UFHealth News Scientists at UF Scripps Biomedical Research have developed a potential medicine for a leading cause of ALS and dementia that works by eliminating disease-causing segments of RNA. The compound restored the health of neurons in the lab...
by admin | Jan 27, 2023 | News & Opinions
By Technology Netowrks Northwestern University-led researchers have created the first highly mature neurons from human induced pluripotent stem cells (iPSCs), a feat that opens new opportunities for medical research and potential transplantation therapies for...
by admin | Jan 26, 2023 | News & Opinions
By Andrea Park, Conor Hale – Fierce Biotech SAN FRANCISCO—After years of stops, starts and stops again, the J.P. Morgan Healthcare Conference has returned to the city by the bay in full form. Below we’ve compiled the biggest medtech news so far,...
by admin | Jan 25, 2023 | News & Opinions
Manipulating Cell Signaling Can Possibly Ensure the Body Has a Healthy Amount of Cells By Stephanie Cajigal – Cedars Sinai A new study led by Cedars-Sinai and the University of California, San Francisco (UCSF), has determined that altering a cellular process can...
by admin | Jan 24, 2023 | News & Opinions
By Allison Gatlin – Investors.com If there’s one overarching theme that investors in biotech stocks should pay attention to in 2023, it’s “genetic medicine, genetic medicine, genetic medicine,” says Christopher Anzalone. Anzalone is...
by admin | Jan 22, 2023 | News & Opinions
Michael Druckman, Meredith Manning, and Ashley Grey – Hogan Lovells Last year, a federal court in California ruled against the U.S. Food and Drug Administration (FDA) in a matter where the government alleged that a stem cell clinic’s products should be...
